13 results match your criteria: "Centre Hospitalier Universitaire Saint-Eloi[Affiliation]"
Diagn Interv Imaging
October 2023
Department of Radiology, Centre Hospitalier Universitaire d'Angers, 49933 Angers, France; Laboratoire HIFIH, UPRES 3859, SFR 4208, Université d'Angers, 49045 Angers, France.
Liver Transpl
January 2019
Hospices Civils de Lyon Hôpital Edouard Herriot Unité de Transplantation Hépatique, Lyon, France.
Liver Transpl
October 2018
Unité de Transplantation Hépatique, et Université Claude Bernard Lyon 1, Hôpital Edouard Herriot, Lyon, France.
De novo malignancies are one of the major late complications and causes of death after liver transplantation (LT). Using extensive data from the French national Agence de la Biomédecine database, the present study aimed to quantify the risk of solid organ de novo malignancies (excluding nonmelanoma skin cancers) after LT. The incidence of de novo malignancies among all LT patients between 1993 and 2012 was compared with that of the French population, standardized on age, sex, and calendar period (standardized incidence ratio; SIR).
View Article and Find Full Text PDFThromb Res
October 2017
Hematology Laboratory, Toulouse University Hospital, Toulouse, France.
Unlabelled: Dabigatran etexilate, rivaroxaban and apixaban (DOACs) are widely used and measurement of their concentration is desirable in certain clinical situations. Target-specific assays are available but limited information exists on their performance especially in their ability to accurately measure low and high concentrations.
Aims: To define, in a multicenter study, the precision and accuracy of DOAC measurements in daily practice.
Liver Transpl
October 2016
Département d'Hépato-Gastroentérologie et de Transplantation Hépatique, Centre Hospitalier Universitaire Saint-Eloi, Université de Montpellier, Montpellier, France.
Recurrence of hepatitis C virus (HCV) after liver transplantation (LT) can rapidly lead to liver graft cirrhosis and, therefore, graft failure and retransplantation or death. The aim of the present study was to assess efficacy and tolerance of sofosbuvir (SOF)-based regimens for the treatment of HCV recurrence in patients with severe fibrosis after LT. The Compassionate Use of Protease Inhibitors in Viral C Liver Transplantation (CULPIT) study is a prospective multicenter cohort including patients with HCV recurrence following LT treated with second generation direct antivirals.
View Article and Find Full Text PDFJ Immunol
January 2016
INSERM U1183, Institute of Regenerative Medicine and Biotherapies, 34295 Montpellier, France; University of Montpellier, 34095 Montpellier, France; and Centre Hospitalier Universitaire Saint Eloi, Institute of Regenerative Medicine and Biotherapies, 34295 Montpellier, France
Promising immunotherapeutic strategies are emerging to restore tolerance in autoimmune diseases by triggering an increase in the number and/or the function of endogenous regulatory T (Treg) cells, which actively control pathological immune responses. Evidence suggests a remarkable heterogeneity in peripheral Treg cells that warrants their better characterization in terms of phenotype and suppressive function, to determine which subset may be optimally suitable for a given clinical situation. We found that repetitive injections of immature dendritic cells expanded Foxp3-negative CD49b(+) Treg cells that displayed an effector memory phenotype.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
November 2015
Assistance Publique-Hôpitaux de Paris Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France; Université Paris-Sud, UMR-S 1193, Villejuif, France; Inserm, Unité 1193, Villejuif, France; DHU Hepatinov, Villejuif, France.
Background & Aims: Fibrosing cholestatic hepatitis (FCH) is a life-threatening disorder that develops in patients with recurrent hepatitis C virus (HCV) infection after liver transplantation. Until recently, therapeutic options have been limited. We evaluated the efficacy and safety of sofosbuvir- and daclatasvir-based regimens.
View Article and Find Full Text PDFHaemophilia
May 2015
Laboratoire d'Hématologie, CHU Carémeau, Nîmes, France.
Development of antibodies (Abs) against factor VIII (FVIII) is a severe complication of haemophilia A treatment. Recent publications suggest that domain specificity of anti-FVIII antibodies, particularly during immune tolerance induction (ITI), might be related to the outcome of the treatment. Obtaining suitable tools for a fine mapping of discontinuous epitopes could thus be helpful.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
January 2016
Department of Dermatology, Hôpital Victor Dupouy Hospital, Argenteuil, France.
Background: Age of the patients and age of onset of psoriasis may have an impact on the disease. There is little information about psoriasis in elderly patients.
Objective: We evaluated epidemiological, clinical aspects, comorbidities and treatments of psoriasis in the elderly (>70 years) patients, and in patients with very late onset psoriasis (onset ≥ 70 years).
Mol Biol Cell
October 2013
Institut de Génétique Moléculaire de Montpellier, CNRS UMR 5535/IFR122, Universities of Montpellier 1 and Montpellier 2, 34293 Montpellier Cedex 5, France Département de Physiologie, Université de Lausanne, CH-1015 Lausanne, Switzerland INSERM U844, Institut des Neurosciences de Montpellier, Centre Hospitalier Universitaire Saint Eloi, Université Montpellier 1, 34295 Montpellier Cedex 5, France Service Immuno-Rhumatologie, Centre Hospitalier Universitaire Lapeyronie, 34093 Montpellier Cedex, France.
Cell invasion targets specific tissues in physiological placental implantation and pathological metastasis, which raises questions about how this process is controlled. We compare dermis and endometrium capacities to support trophoblast invasion, using matching sets of human primary fibroblasts in a coculture assay with human placental explants. Substituting endometrium, the natural trophoblast target, with dermis dramatically reduces trophoblast interstitial invasion.
View Article and Find Full Text PDFLiver Transpl
November 2009
Service d'Hépato-Gastroentérologie et Transplantation Hépatique, Centre Hospitalier Universitaire Saint Eloi, Montpellier, France.
1. Despite methodological problems in estimating the true incidence of new-onset diabetes (NODM), it is generally accepted that this is a common complication of liver transplantation (LT), with the mean reported incidence varying between 7% and 30%. 2.
View Article and Find Full Text PDFArch Pediatr
March 2001
Service de neuropédiatrie, centre hospitalier universitaire Saint-Eloi, avenue Bertin-Sans, 34295 Montpellier, France.
Unlabelled: Acute transverse myelitis is a rare disorder in childhood. It usually occurs as a post-infectious disease, but a precise infectious agent is identified in only 20% of cases.
Observation: The diagnosis of acute transverse myelitis was made in a 5.
Ann Med Interne (Paris)
September 1996
Laboratoire d'Hématologie et Service d'Hépato-Gastroentérologie, Centre Hospitalier Universitaire Saint-Eloi, Montpellier, France.